My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 180

    1.

    TNFRSF1B in genetic predisposition to clinical neuropathy and effect on HDL cholesterol and glycosylated hemoglobin in type 2 diabetes.

    Benjafield AV, Glenn CL, Wang XL, Colagiuri S, Morris BJ.

    Diabetes Care. 2001 Apr;24(4):753-7.PMID: 11315843 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease.

    Benjafield AV, Wang XL, Morris BJ.

    J Mol Med. 2001 Apr;79(2-3):109-15.PMID: 11357933 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.

    Vendrell J, Broch M, Fernandez-Real JM, Gutiérrez C, Simón I, Megia A, Gallart L, Ricart W, Richart C.

    Diabet Med. 2005 Apr;22(4):387-92.PMID: 15787661 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.

    Bavirti S, Ghanaat F, Tayek JA.

    Endocr Pract. 2003 Nov-Dec;9(6):487-93.PMID: 14715475 [PubMed - indexed for MEDLINE]Related articles

    6.

    The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

    Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

    Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.

    Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A.

    J Diabetes Complications. 2001 May-Jun;15(3):150-7.PMID: 11358684 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.

    Forsblom CM, Sane T, Groop PH, Tötterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepäntalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L.

    Diabetologia. 1998 Nov;41(11):1253-62.PMID: 9833930 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol.

    Kolz M, Baumert J, Müller M, Khuseyinova N, Klopp N, Thorand B, Meisinger C, Herder C, Koenig W, Illig T.

    BMC Med Genet. 2008 Feb 25;9:9.PMID: 18298826 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.

    Ukkola O, Salonen J, Kesäniemi YA.

    J Endocrinol Invest. 2005 Nov;28(10):871-5.PMID: 16419488 [PubMed - indexed for MEDLINE]Related articles

    11.

    Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects.

    Kowalska I, Straczkowski M, Nikołajuk A, Krukowska A, Kinalska I, Górska M.

    Eur J Endocrinol. 2006 Feb;154(2):319-24.PMID: 16452547 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes.

    Pontiroli AE, Monti LD, Pizzini A, Piatti P.

    Diabetes Care. 2000 Sep;23(9):1359-64.PMID: 10977033 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.

    Jokl R, Klein RL, Lopes-Virella MF, Colwell JA.

    Diabetes Care. 1995 Aug;18(8):1150-5.PMID: 7587850 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.

    Becker A, van der Does FE, van Hinsbergh VW, Heine RJ, Bouter LM, Stehouwer CD.

    Neth J Med. 2003 Apr;61(4):129-36.PMID: 12852722 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36.

    Speirs HJ, Wang WY, Benjafield AV, Morris BJ.

    J Hypertens. 2005 Aug;23(8):1491-6.PMID: 16003175 [PubMed - indexed for MEDLINE]Related articles

    16.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    17.

    The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.

    Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W.

    Atherosclerosis. 2005 Dec;183(2):336-41. Epub 2005 Apr 19.PMID: 16285997 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship between myoinositol influx and lipids in diabetic neuropathy.

    Simmons D, Ng LL, Bomford J.

    Acta Diabetol. 1993;30(4):233-7.PMID: 8180415 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Orchard TJ, Forrest KY, Kuller LH, Becker DJ; Pittsburgh Epidemiology of Diabetes Complications Study.

    Diabetes Care. 2001 Jun;24(6):1053-9.PMID: 11375370 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

    Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

    Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.PMID: 17283301 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity